Account
Inquiry
Amble Tirzepatide (LY3437943) is a novel peptide compound with triple agonist activity targeting GLP-1, GIP, and glucagon receptors. This innovative molecule demonstrates significant potential in metabolic disorder research, particularly for type 2 diabetes and obesity management studies.
The compound appears as a white lyophilized powder with molecular weight of 4731.33 and purity exceeding 99%. Each vial contains precisely measured 10mg of active peptide, ensuring accurate dosing for experimental protocols. Proper storage at 2-8°C maintains stability and potency.
In preclinical studies, Amble Tirzepatide has shown remarkable efficacy in glucose regulation and weight reduction, with some models demonstrating up to 24.2% body weight reduction. These effects make it particularly interesting for metabolic syndrome research applications.
The peptide sequence features specialized modifications including Aib residues and fatty acid side chains that enhance receptor binding and prolong biological activity. This molecular design contributes to the compound's superior pharmacokinetic profile observed in research settings.
For research institutions requiring larger quantities, we offer bulk packaging options from 1g to 1kg. All batches undergo rigorous quality control including HPLC purity verification and impurity profiling to ensure consistent research outcomes.
Amble Tirzepatide represents an important tool for investigating next-generation metabolic therapies. Its unique triple agonist mechanism provides researchers with novel insights into simultaneous modulation of multiple hormonal pathways.
